Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Pick a strategy above and run the backtest to see its simulated performance on TBPH.
Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.
TBPH is priced at $17.03 right now, flat on the session. That puts its market value at $884.18M, 3323rd largest among the 3753 stocks we cover.
The stock's 52-week band runs $13.08 to $21.03, and the latest print sits 19.0% under the top end of it.
Revenue for the quarter ended Jun 2026 was $20.73M, down 20.9% from a year earlier, and a net loss of $5.90M.
Buyers are paying 16.4 times trailing earnings, 738% above its five-year average of 2.0. The median for its industry group is 19.1.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 2 factors below, ranked against the 3752 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Trading closer to its 52-week high than most peers scores higher.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
TBPH is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Morningstar’s fair value model puts the stock at $16.49, so shares trade 3.3% above that estimate. On earnings multiple, it sits in the 86th percentile of its own five-year valuation range (pricier than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 8, 2026 12:00 am ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,752 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 16.4x earnings, TBPH looks cheap against the market, and trades 14% below the 19.1x median among Biotechnology names. The two comparisons do not always agree.
$17.03 is the latest print for TBPH, a move of +0.00% against yesterday's close of $17.03. Today's low and high so far: $0.00 and $0.00.
Equity value comes to $884.18M at the current price. By that measure it is number 3323 of the 3753 names in our coverage.
Buyers pay 16.4 times the last twelve months of profit (EPS $2.06). Averaged over five years the multiple has been 2.0, and today's level ranks in the 86th percentile of its own history.
The year's floor is $13.08 and the ceiling $21.03. Shares are 19.0% away from that ceiling.
Our data shows no dividend paid by Theravance Biopharma(Delisted) over the trailing twelve months.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on TBPH.